RTPR Allen & Overy has advised the shareholders of A&D Pharma on the sale of the entire group to the Dr. Max pharmacy network, owned by Penta Investments. Musat & Asociatii reportedly advised the buyers on the transaction, which remains subject to approval by Romania's Competition Council.
RTPR Allen & Overy describes A&D Pharma group as "the largest pharma group in Romania, operating wholesale, retail and marketing & sales services for pharmaceutical products and it also has operations in CEE."
The RTPR Allen & Overy team included Managing Partner Costin Taracila, Counsel Alina Stavaru, and Junior Associate Mihnea Radu, along with lawyers from Allen & Overy’s Amsterdam, Prague, and Milan offices. According to RTPR Allen & Overy, "the shareholders were assisted by two of the most prominent M&A consultants on the market, Radu Stoicoviciu and Raluca Nita."
Editor’s note: After this article was published Musat & Asociatii confirmed that it had advised Penta Investments on the acquisition. Its team consisted of Senior Partner Gheorghe Musat, seconded by Partner Razvan Stoicescu and Senior Associate Adrian Danciu. As regards the competition and life sciences component of the transaction, the team was coordinated by Partner Paul Buta and included Managing Associates Dan Minoiu, Manuela Lupeanu, and Razvan Pele.
Subsequently, on April 18, 2018, RTPR Allen & Overy announced that the deal had successfully closed.
